-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JoL6CL1k9jMJ8vZwKVzsbNpoFzWaRiHCv2qAUWH5lOcylb6UBlJlnU9gcEANfV/a mGf3vLvyV3O1XPYDLuvsXg== 0001121888-05-000101.txt : 20051019 0001121888-05-000101.hdr.sgml : 20051019 20051019142851 ACCESSION NUMBER: 0001121888-05-000101 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051017 ITEM INFORMATION: Other Events FILED AS OF DATE: 20051019 DATE AS OF CHANGE: 20051019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 051144913 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 8-K 1 form8k.htm CHANGE OF PRESIDENT change of president

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________

FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) [October 17, 2005]



BioSpecifics Technologies Corp
(Exact name of registrant as specified in its charter)




Delaware
0-19879
11-3054851
(State or Other Jurisdiction
(Commission File Number)
(I.R.S. Employer
Of Incorporation)
  
Identification No.)
     
 

35 Wilbur Street, Lynbrook, NY 11563
(Address of Principal Executive Office) (Zip Code)


516.593.7000
(Registrant’s telephone number, including area code)


Not Applicable
(Former Name or Former Address, If Changed Since Last Report.)









Item 8.01. Other events

On October 17, 2005, the Board of Directors of BioSpecifics Technologies Corp. accepted the resignation of Edwin H. Wegman as its President. Mr. Wegman remains with the Company as its Chairman and Chief Executive Officer. The Board of Directors elected Thomas L. Wegman to the position of President.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

BioSpecifics Technologies Corp.
By: /s/ Lawrence Dobroff
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Lawrence Dobroff
Chief Financial Officer
Dated: October 19, 2005





3



     




4


INDEX TO EXHIBITS


Exhibit No.
     
Exhibit Title
     
     

 -----END PRIVACY-ENHANCED MESSAGE-----